Design, synthesis and in vitro antiproliferation activity of some 2-aryl and -heteroaryl benzoxazole derivatives - Revised Supporting Information R2.docx

<strong>General experimental procedures</strong>

<strong>General procedures for the synthesis of compounds</strong>

<strong>Characterization of the synthesized compounds</strong>

<strong>Copies of 1H NMR and 1H NMR spectrums</strong>

<strong>Table S1.</strong> The percentages of live, necrotic, early, and late apoptotic cells and apoptosis/ necrosis ratio in the control and the compounds <strong>BK65</strong>, <strong>BK76</strong>, <strong>BK82,</strong> and <strong>BK89</strong> treated MCF-7 cells.
 <strong>Table S2.</strong> The percentages of live, early, and late apoptotic cells, necrotic, and apoptosis/necrosis ratio in the control and the compounds <strong>BK65</strong>, <strong>BK76</strong>, <strong>BK82,</strong> and <strong>BK89</strong> treated WI-38 cells. 

<strong>Figure S1.</strong> Cell-cycle analysis of the effects of 5 µg/µL for 24 h on the cell cycle distribution in MCF-7 cells.

<strong>Figure S2.</strong> Cell-cycle phase percentages of the compounds <strong>BK65</strong>, <strong>BK76</strong>, <strong>BK82</strong> and <strong>BK89</strong>.
<br>